- Home
- CRBD vs XNCR Comparison
CRBD vs XNCR Comparison
Compare CRBD & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBD
- XNCR
- Stock Information
- Founded
- CRBD N/A
- XNCR 1997
- Country
- CRBD
- XNCR United States
- Employees
- CRBD N/A
- XNCR 250
- Industry
- CRBD
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- CRBD
- XNCR Health Care
- Exchange
- CRBD NYSE
- XNCR Nasdaq
- Market Cap
- CRBD N/A
- XNCR 568.3M
- IPO Year
- CRBD N/A
- XNCR 2013
- Fundamental
- Price
- CRBD $23.87
- XNCR $8.32
- Analyst Decision
- CRBD
- XNCR Buy
- Analyst Count
- CRBD 0
- XNCR 9
- Target Price
- CRBD N/A
- XNCR $30.13
- AVG Volume (30 Days)
- CRBD N/A
- XNCR 1.0M
- Earning Date
- CRBD N/A
- XNCR 05-07-2025
- Dividend Yield
- CRBD N/A
- XNCR N/A
- EPS Growth
- CRBD N/A
- XNCR N/A
- EPS
- CRBD N/A
- XNCR N/A
- Revenue
- CRBD N/A
- XNCR $127,228,000.00
- Revenue This Year
- CRBD N/A
- XNCR N/A
- Revenue Next Year
- CRBD N/A
- XNCR $29.14
- P/E Ratio
- CRBD N/A
- XNCR N/A
- Revenue Growth
- CRBD N/A
- XNCR N/A
- 52 Week Low
- CRBD N/A
- XNCR $7.16
- 52 Week High
- CRBD N/A
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- CRBD N/A
- XNCR 36.86
- Support Level
- CRBD N/A
- XNCR $7.89
- Resistance Level
- CRBD N/A
- XNCR $9.37
- Average True Range (ATR)
- CRBD 0.00
- XNCR 0.80
- MACD
- CRBD 0.00
- XNCR -0.14
- Stochastic Oscillator
- CRBD 0.00
- XNCR 6.23
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.